Qualigen Therapeutics Stock Price on September 6, 2024
| QLGN Stock | USD 4.47 0.31 6.49% |
Below is the normalized historical share price chart for Qualigen Therapeutics extending back to June 24, 2015. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Qualigen Therapeutics stands at 4.47, as last reported on the 27th of November, with the highest price reaching 4.71 and the lowest price hitting 4.14 during the day.
If you're considering investing in Qualigen Stock, it is important to understand the factors that can impact its price. Qualigen Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of -0.13, which implies the firm had a -0.13% return per unit of risk over the last 3 months. Qualigen Therapeutics exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Qualigen Therapeutics' Risk Adjusted Performance of (0.10), coefficient of variation of (694.77), and Variance of 45.49 to confirm the risk estimate we provide.
At this time, Qualigen Therapeutics' Common Stock Shares Outstanding is very stable compared to the past year. As of the 27th of November 2024, Capital Stock is likely to grow to about 66.5 K, though Total Stockholder Equity is likely to grow to (2 M). . As of the 27th of November 2024, Price To Sales Ratio is likely to drop to 25.45. In addition to that, Price Earnings Ratio is likely to drop to -10.91. Qualigen Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 24th of June 2015 | 200 Day MA 12.6091 | 50 Day MA 6.6954 | Beta 0.135 |
Qualigen |
Sharpe Ratio = -0.1272
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | QLGN |
Estimated Market Risk
| 6.8 actual daily | 60 60% of assets are less volatile |
Expected Return
| -0.87 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.13 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Qualigen Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Qualigen Therapeutics by adding Qualigen Therapeutics to a well-diversified portfolio.
Price Book 0.4055 | Enterprise Value Ebitda (0.05) | Price Sales 0.3869 | Shares Float 242.9 K | Wall Street Target Price 5 |
Qualigen Therapeutics Main Headline on 6th of September 2024
Univest Securities, LLC Announces Closing of 3.46 Million Re... by finance.yahoo.com
New York, Sept. 06, 2024 -- Univest Securities, LLC , a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing of registered direct offering of 14,724,058 shares of common stock priced at 0.130 per share, with pre-funded warrants exercisable for 11,972,754 shares with respect to the registered direct offering for its client Qualigen Therapeutics, Inc. NASDAQ
Qualigen Therapeutics Valuation on September 6, 2024
It is possible to determine the worth of Qualigen Therapeutics on a given historical date. On September 6, 2024 Qualigen was worth 8.05 at the beginning of the trading date compared to the closed value of 7.99. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Qualigen Therapeutics stock. Still, in general, we apply an absolute valuation method to find Qualigen Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Qualigen Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Qualigen Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 7.49 | 8.57 | 7.05 | 8.20 | 37,212 | |
09/06/2024 | 8.05 | 8.20 | 7.50 | 7.99 | 9,832 |
| 7.90 | 8.00 | 7.38 | 7.75 | 5,693 |
| Backtest Qualigen Therapeutics | | | Qualigen Therapeutics History | | | Qualigen Therapeutics Valuation | Previous | Next |
Qualigen Therapeutics Trading Date Momentum on September 6, 2024
| On September 09 2024 Qualigen Therapeutics was traded for 7.75 at the closing time. The top price for the day was 8.00 and the lowest listed price was 7.38 . The trading volume for the day was 5.7 K. The trading history from September 9, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 3.00% . The trading delta at closing time against the current closing price is 9.51% . |
Qualigen Therapeutics Fundamentals Correlations and Trends
By evaluating Qualigen Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Qualigen Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Qualigen financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Qualigen Therapeutics Stock history
Qualigen Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Qualigen is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Qualigen Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Qualigen Therapeutics stock prices may prove useful in developing a viable investing in Qualigen Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 5.1 M | 5.3 M | |
| Net Loss | -16.8 M | -17.6 M |
Qualigen Therapeutics Stock Technical Analysis
Qualigen Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Qualigen Therapeutics Period Price Range
Low | November 27, 2024
| High |
0.00 | 0.00 |
Qualigen Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Qualigen Therapeutics November 27, 2024 Market Strength
Market strength indicators help investors to evaluate how Qualigen Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Qualigen Therapeutics shares will generate the highest return on investment. By undertsting and applying Qualigen Therapeutics stock market strength indicators, traders can identify Qualigen Therapeutics entry and exit signals to maximize returns
Qualigen Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Qualigen Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Qualigen Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Qualigen to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.10) | |||
| Jensen Alpha | (1.07) | |||
| Total Risk Alpha | (2.04) | |||
| Treynor Ratio | (1.28) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Qualigen Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. To learn how to invest in Qualigen Stock, please use our How to Invest in Qualigen Therapeutics guide.You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Qualigen Therapeutics. If investors know Qualigen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Qualigen Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 3.6 K | Revenue Per Share 1.034 | Quarterly Revenue Growth 0.137 | Return On Assets (0.75) | Return On Equity (8.42) |
The market value of Qualigen Therapeutics is measured differently than its book value, which is the value of Qualigen that is recorded on the company's balance sheet. Investors also form their own opinion of Qualigen Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Qualigen Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Qualigen Therapeutics' market value can be influenced by many factors that don't directly affect Qualigen Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Qualigen Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Qualigen Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Qualigen Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.